Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-02-07
1991-05-28
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142282, 514255, 514326, 514398, 540451, 544 61, 544359, 546210, 548337, A61K 3155, C07D23366, C07D41912, C07D40312
Patent
active
050195727
ABSTRACT:
Imidazole compounds including imidazoles and imidazolium salts, and their use as transglutaminase inhibitors are disclosed.
REFERENCES:
patent: 3636003 (1972-01-01), Doebel et al.
patent: 3915980 (1975-10-01), Gebert et al.
patent: 4137320 (1979-01-01), Tedeschi
patent: 4218476 (1980-08-01), Joensson et al.
patent: 4265898 (1981-05-01), Horstmann et al.
patent: 4460598 (1984-07-01), Lautenschlager et al.
patent: 4619944 (1986-10-01), Youssefyeh et al.
Baldwin John J.
Claremon David A.
Remy David C.
Caruso Charles M.
Chang Celia
Merck & Co. , Inc.
Robertson Alice O.
Rotman Alan L.
LandOfFree
Imidazole compounds and their use as transglutaminase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole compounds and their use as transglutaminase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole compounds and their use as transglutaminase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36202